Response Rates of Patients With Metastatic Melanoma to High-Dose Intravenous Interleukin-2 After Prior Exposure to Alpha-Interferon or Low-Dose Interleukin-2

Por Weinreich, David M., Rosenberg, Steven A.
Publicado em 2002

Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity

Por Puhlmann, Markus, Weinreich, David M, Farma, Jeffrey M, Carroll, Nancy M, Turner, Ewa M, Alexander, H Richard
Publicado em 2005

Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Ohtsu, Atsushi, Fuse, Nozomu, Yoshino, Takayuki, Tahara, Makoto, Shibayama, Kazuhiro, Takubo, Takatoshi, Weinreich, David M.
Publicado em 2012

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

Por Lu, Jian-Feng, Rasmussen, Erik, Karlan, Beth Y., Vergote, Ignace B., Navale, Lynn, Kuchimanchi, Mita, Melara, Rebeca, Stepan, Daniel E., Weinreich, David M., Sun, Yu-Nien
Publicado em 2012